Other Biodefense Products:
SGX202

SGX202: Radiation Injury Therapy

Soligenix is also exploring the features of several formulations of oral beclomethasone dipropionate (BDP) in the setting of radiation injury, since one of the immediate consequences of radiation exposure is gastrointestinal inflammation and loss of intestinal epithelial functions. The local anti-inflammatory action of BDP is anticipated to mitigate the tissue damage following radiation exposure due to excessive influx of neutrophils and cellular damage caused by release of cytokines.